Hemispherx Biopharma (HEB) Announces Compliance with NYSE Continued Listing Standards

September 19, 2016 8:37 AM EDT
Get Alerts HEB Hot Sheet
Trade HEB Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Hemispherx Biopharma (NYSE: HEB) announced today that, based on a notice received on September 15, 2016 from the New York Stock Exchange, Inc., the Company has regained compliance with the NYSE MKT’s continued listing standards set forth in Part 10 of the NYSE MKT Company Guide.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment